BENITEC BIOPHARMA INC.
3940 Trust Way
Hayward, California 94545
October 1, 2020
VIA EDGAR
Tim Buchmiller
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
| Re: | Benitec Biopharma Inc. |
Registration Statement on Form S-1 (File No. 333-246314)
Dear Mr. Buchmiller:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-246314), as amended, so that it may become effective at 9:00 a.m. Eastern Time on October 2, 2020, or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, | ||||
| BENITEC BIOPHARMA INC. | ||||
| By: | /s/ Dr. Jerel Banks | |||
| Name: | Dr. Jerel Banks | |||
| Title: | Chief Executive Officer | |||
[Signature Page to Acceleration Request]
